<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the immunophenotype and overall survival of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) classified according to the 2008 World Health Organization classification of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of hematopoietic and lymphoid tissues </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Five hundred cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> were retrospectively analyzed with histologic review, immunohistochemistry, gene rearrangement study, in situ hybridization and fluorescence in situ hybridization </plain></SENT>
<SENT sid="2" pm="."><plain>Follow-up data were collected </plain></SENT>
<SENT sid="3" pm="."><plain>The overall survival rates of germinal center B-cell (GCB) and non-germinal center B-cell (non-GCB) subtypes, as well as those of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, not otherwise specified (NOS) and Epstein-Barr virus (EBV)-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> of the elderly, were compared </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>-NOS was the commonest subtype which accounted for 77.2% (386/500) of the cases </plain></SENT>
<SENT sid="5" pm="."><plain>EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> of the elderly, primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> of central <z:mp ids='MP_0008912'>nervous</z:mp> system, primary mediastinal (thymic) large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and T cell/histiocyte-rich large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> accounted for 9.4% (47/500), 4.4% (22/500), 2.8% (14/500) and 2.6% (13/500), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>68.5% (219/320) of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>-NOS belonged to non-GCB subtype </plain></SENT>
<SENT sid="7" pm="."><plain>The percentage of GCB subtype and CD5-positive subtype were 28.4% (91/320) and 3.1% (10/320), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Comparison of the overall survival, GCB and non-GCB immunophenotypic groups have no significant difference (P = 0.93) </plain></SENT>
<SENT sid="9" pm="."><plain>And the same result in which of the EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> of the elderly and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>-NOS group, before and after age matched (P = 0.13 and 0.28, respectively) </plain></SENT>
<SENT sid="10" pm="."><plain>A double-hit <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was found by FISH detection, which presenting as gray zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: By using Hans algorithm, GCB and non-GCB subtypes show no significant difference in overall survival </plain></SENT>
<SENT sid="12" pm="."><plain>EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> of the elderly and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>-NOS also do not have significant difference in overall survival </plain></SENT>
<SENT sid="13" pm="."><plain>Fluorescence in situ hybridization technique is helpful in identification of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> with rare phenotypes </plain></SENT>
</text></document>